 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | 15N2-tofacitinib (TD-3504) / Theravance Biopharma
Trial completion: TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC) (clinicaltrials.gov) - Dec 5, 2017
P1a, N=32, Completed, Sponsor: Theravance Biopharma R & D, Inc.
Recruiting --> Completed
- 15N2-tofacitinib (TD-3504) / Theravance Biopharma
Clinical: TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC) (clinicaltrials.gov) - Jul 21, 2017
P1a, N=32, Recruiting, Sponsor: Theravance Biopharma R & D, Inc.
Recruiting --> Completed Not yet recruiting --> Recruiting
- | 15N2-tofacitinib (TD-3504) / Theravance Biopharma
Clinical: TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC) (clinicaltrials.gov) - Apr 5, 2017
P1a, N=32, Not yet recruiting, Sponsor: Theravance Biopharma R & D, Inc.